We assign a technical rating of 1 out of 10 to CRBP. CRBP scores bad on all fronts: it is a bad performer in the overall market and both the medium and short term pictures are negative.
The short term trend is neutral, while the long term trend is still negative. We need to see a little more continued positive action to make this really interesting.
When comparing the yearly performance of all stocks, CRBP is a bad performer in the overall market: 95% of all stocks are doing better.
CRBP is one of the lesser performing stocks in the Biotechnology industry. 74% of 568 stocks in the same industry do better.
CRBP is currently trading near the lower end of its 52 week range, which is not a good sign. CRBP is lagging the S&P500 Index which is trading in the middle of its 52 week range.
Considerably lower volume is observed in the last couple of days, which is not what you would like to see during a strong up movement.
In the last month CRBP has a been trading in the 4.64 - 6.84 range, which is quite wide. It is currently trading near the high of this range.
Prices have been rising strongly lately, it may be a good idea to wait for a consolidation or pullback before considering an entry.